Show simple item record

dc.contributor.authorAnthony, P Pen_GB
dc.contributor.authorRamani, Pen_GB
dc.date.accessioned2007-05-21T14:45:15Zen_GB
dc.date.accessioned2011-01-25T10:08:09Zen_GB
dc.date.accessioned2013-03-20T17:08:11Z
dc.date.issued1991-01en_GB
dc.description.abstractA new monoclonal antibody, QB-END/10, raised against the CD34 antigen in human endothelial cell membranes and haemopoietic progenitor cells, was studied for its usefulness as a marker of neoplastic vascular cells in 21 angiosarcomas and seven malignant haemangioendotheliomas of the liver. QB-END/10 was both more sensitive and more specific than Von Willebrand factor (VWF) and Ulex europaeus 1 agglutinin (UEA-1) in labelling endothelial cells and it did not cross react with epithelia as UEA-1 often does. Staining was uniformly strong and clear in all histological variants of these two tumours. QB-END/10 should prove particularly useful in the differential diagnosis of malignant vascular tumours of the liver.en_GB
dc.identifier.citationJournal of Clinical Pathology, 1991, 44(1):29-32en_GB
dc.identifier.urihttp://hdl.handle.net/10036/12005en_GB
dc.language.isoen_USen_GB
dc.titleEndothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.en_GB
dc.typeArticleen_GB
dc.date.available1991-01en_GB
dc.date.available2007-05-21T14:45:15Zen_GB
dc.date.available2011-01-25T10:08:09Zen_GB
dc.date.available2013-03-20T17:08:11Z
dc.identifier.issn0021-9746en_GB
dc.identifier.issn1472-4146en_GB
dc.format.digYESen_GB
dc.identifier.journalJournal of Clinical Pathologyen_GB
dc.identifier.pmcid497010en_GB
dc.identifier.pmid1705261en_GB


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record